RxDoctor Payments Data

Adam Kemp, MD

Pain Medicine · Eugene, ORNPI 1811342967

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (31.5%), travel and lodging and consulting fees — rather than concentrated in one kind of arrangement. 15 manufacturers reported payments, led by Boston Scientific at 44.9% of the total. Reporting peaked in 2021 at $8,975 and has fallen 76.7% since, to $2,088 in 2025.

$27,664in general payments, 2019–2025

Across 232 payments — averaging $119.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$12K
  • Medtronic$8K
  • Nevro Corp.$3K
  • Abbott$2K
  • Nalu Medical, Inc.$2K
  • Globus Medical$188
  • plus $668 from 9 others

What the payments were for

  • Consulting fees$6,80025%
  • Grants$5,00018%
  • Travel & lodging$7,08126%
  • Food & beverage$8,72432%
  • Education$590%

General payments by program year

20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$27,664 in reported general payments places this provider in the 85th percentile of 57 pain medicine providers in Oregon.

See all pain medicine providers in Oregon

Medicare billing

Part B allowed, 2024
$162,169
Medicare patients
240
Services billed
3,051

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OxycontinOxycodone Hcl15$4,017
Buprenorphine12$3,060
Buprenorphine Hcl32$2,414
Oxycodone Hcl92$1,989
Celecoxib45$1,876
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen73$1,849
Tizanidine Hcl35$931
Tramadol Hcl22$718
Gabapentin42$495
Pregabalin22$349
Hydromorphone Hcl11$204
Alprazolam120$121
Meloxicam19$38
Lorazepam23$21

Paid to pharmacies, not to this prescriber.

Other pain medicine in Eugene

See the full list for Oregon

Where these figures come from

Is this you, or does something look wrong? →